Lorazepam is a benzodiazepine derivative that is globally used for the therapy of anxiety and insomnia. A 51-year-old Japanese man with yellowish discoloration of the eyes and skin and pruritus was admitted due to liver dysfunction. He had taken lorazepam approximately 5 months prior to this admission. The clinical presentation and pathologic findings in the liver were consistent with drug-induced liver injury. After cessation of lorazepam, treatment with Stronger neo-minophagen C and ursodeoxycholic acid was started, and his liver injury resolved after 59 days. This case must serve as a warning to physicians to be aware of the possibility of unexpected liver injury caused by lorazepam.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167696PMC
http://dx.doi.org/10.1159/000492209DOI Listing

Publication Analysis

Top Keywords

liver injury
16
drug-induced liver
8
liver
6
lorazepam
5
lorazepam drug-induced
4
injury
4
injury lorazepam
4
lorazepam benzodiazepine
4
benzodiazepine derivative
4
derivative globally
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!